Dentsply Sirona, Inc. (NASDAQ: XRAY)
Hagens Berman Sobol Shapiro LLP alerts investors in Dentsply Sirona Inc. (NASDAQ: XRAY) to the February 19, 2019 Lead Plaintiff deadline in the securities class action pending in the U.S. District Court for the Eastern District of New York.
IIf you (a) purchased or otherwise acquired shares of Dentsply Sirona, Inc. (NASDAQ: XRAY) between February20, 2014 and August 7, 2018 (the “Class Period”) OR (b) held Dentsply International, Inc. (“Dentsply Intl.”) shares as of December 2, 2015 and were entitled to vote with respect to Dentsply Intl.’s acquisition of Sirona Dental Systems, Inc. and suffered losses contact Hagens Berman Sobol Shapiro LLP. For more infomation contact Reed Kathrein, who is leading the firm's investigation, by calling 510-725-3000 or emailing XRAY@hbsslaw.com.
On February 29, 2016, Dentsply Intl. and Sirona Dental Systems, Inc. completed their merger to form Dentsply Sirona Inc.
On August 7, 2018, Dentsply Sirona announced its second quarter 2018 financial results, including a goodwill and intangible impairment charge of $1.265 billion.
Management also slashed adjusted EPS guidance for 2018 to the range of $2.00 to $2.15 per share, down from its previous estimate of $2.55 to $2.65 per share.
This news drove the price of Dentsply Sirona shares down as much as $9.03, or about 18.5%, to close at $39.41 on August 7, 2018.
More recently, the Company announced a restructuring plan and, reporting 3Q 2018 financial results, disclosed “Technology & Equipment revenues declined by 11.3% in the third quarter of 2018 as revenues were impacted by a significant amount of inventory destocking in the third quarter.”
“We’re focused on investors’ losses and whether management’s statements about the Company’s Technologies and Equipment segment and certain distributor relationships may have misled investors,” said Hagens Berman partner Reed Kathrein.
Hagens Berman purchases advertisements on search engines, social media sites and other websites. Transmission of the information contained or available through this website is not intended to create, and receipt does not constitute, an attorney-client relationship. If you seek legal advice or representation by Hagens Berman, you must first enter a formal agreement. All information contained in any transmission is confidential and Hagens Berman agrees to protect information against unauthorized use, publication or disclosure. This site is regulated by the Washington Rules of Professional Conduct.